We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Comscore
SCOR
$109M
| $5.23M | 0.03% |
5,110
+3,800
| +290% | +$3.58M |
|
|
RSTI
402
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $5.23M | 0.03% |
215,670
+11,000
| +5% | +$277K |
|
403
Brixmor Property Group
BRX
$9.32B
| $5.19M | 0.03% |
195,425
-443,036
| -69% | -$11.6M |
|
404
CVR Energy
CVI
$3.13B
| $5.13M | 0.03% |
120,530
+29,694
| +33% | +$1.17M |
|
405
Vishay Intertechnology
VSH
$5.43B
| $5.12M | 0.03% |
370,659
+270,641
| +271% | +$3.73M |
|
406
Leidos
LDOS
$17.3B
| $5.09M | 0.03% |
+121,306
| New | +$5.27M |
|
407
Lattice Semiconductor
LSCC
$18.5B
| $5.05M | 0.03% |
796,938
-111,152
| -12% | -$737K |
|
|
NBG
408
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $5.03M | 0.03% |
3,929,067
+3,550,039
| +937% | +$5.21M |
|
|
VALE.P
409
DELISTED
Vale S A
VALE.P
| $5.02M | 0.03% |
1,035,700
+152,770
| +17% | +$966K |
|
410
Stantec
STN
$8.39B
| $5M | 0.03% |
209,032
-570,816
| -73% | -$14.5M |
|
|
SNBR
411
DELISTED
Sleep Number
SNBR
| $4.98M | 0.03% |
144,522
+63,410
| +78% | +$1.97M |
|
412
J&J Snack Foods
JJSF
$1.71B
| $4.92M | 0.03% |
46,139
-25,612
| -36% | -$2.66M |
|
413
NETGEAR
NTGR
$635M
| $4.92M | 0.03% |
149,552
+36,453
| +32% | +$1.21M |
|
|
SYKE
414
DELISTED
SYKES Enterprises Inc
SYKE
| $4.88M | 0.03% |
196,439
+25,512
| +15% | +$600K |
|
|
DX
415
Dynex Capital
DX
$3.21B
| $4.85M | 0.03% |
191,014
-40,292
| -17% | -$1.01M |
|
|
ICON
416
DELISTED
Iconix Brand Group, Inc.
ICON
| $4.84M | 0.03% |
14,374
+6,741
| +88% | +$2.32M |
|
417
Truist Financial
TFC
$64B
| $4.79M | 0.03% |
122,789
+59,702
| +95% | +$2.25M |
|
|
OUTR
418
DELISTED
OUTERWALL INC
OUTR
| $4.79M | 0.03% |
72,399
+58,885
| +436% | +$3.94M |
|
|
TI
419
DELISTED
Telecom Italia
TI
| $4.78M | 0.03% |
411,632
-273,950
| -40% | -$3.11M |
|
|
SSI
420
DELISTED
Stage Stores Inc
SSI
| $4.75M | 0.03% |
207,099
+131,202
| +173% | +$2.82M |
|
421
CONMED
CNMD
$1.47B
| $4.72M | 0.03% |
93,408
-36,905
| -28% | -$1.81M |
|
422
Smith & Nephew
SNN
$12.6B
| $4.71M | 0.03% |
137,857
-686,319
| -83% | -$24.3M |
|
423
Campbell Soup
CPB
$6.87B
| $4.7M | 0.03% |
+101,000
| New | +$4.66M |
|
|
UAM
424
DELISTED
Universal American Corp
UAM
| $4.67M | 0.03% |
437,042
+95,655
| +28% | +$899K |
|
|
ISIL
425
DELISTED
Intersil Corp
ISIL
| $4.65M | 0.03% |
324,828
+222,958
| +219% | +$3.31M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.